Steven II - BioLargo Pres Inc
| BLGO Stock | USD 0.25 0.01 3.85% |
Insider
Steven II is Pres Inc of BioLargo
| Age | 64 |
| Phone | 888 400 2863 |
| Web | https://www.biolargo.com |
BioLargo Management Efficiency
The company has return on total asset (ROA) of (0.6884) % which means that it has lost $0.6884 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6331) %, meaning that it created substantial loss on money invested by shareholders. BioLargo's management efficiency ratios could be used to measure how well BioLargo manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Claudio Alves | Vale SA ADR | 50 | |
| Connie Duckworth | MP Materials Corp | 65 | |
| David Buckley | Piedmont Lithium Ltd | N/A | |
| Ana Gardner | Sigma Lithium Resources | 54 | |
| Denis Cuenca | Vale SA ADR | N/A | |
| Marcello Spinelli | Vale SA ADR | 51 | |
| Jose Coelho | Vale SA ADR | 52 | |
| Eduardo Filho | Vale SA ADR | 65 | |
| Erin Sanders | Piedmont Lithium Ltd | N/A | |
| BSc Fcis | Sigma Lithium Resources | N/A | |
| Ivan Fadel | Vale SA ADR | N/A | |
| Brian BSc | Sigma Lithium Resources | N/A | |
| Marcelo CFA | Sigma Lithium Resources | 50 | |
| Isabella Albuquerque | Vale SA ADR | 49 | |
| Marcelo Silva | Vale SA ADR | 49 | |
| Bruce Czachor | Piedmont Lithium Ltd | 63 | |
| Patricia Bentes | Vale SA ADR | N/A | |
| Eng BE | Piedmont Lithium Ltd | 49 | |
| Robert Mintak | Standard Lithium | 62 | |
| BCom HBCom | Piedmont Lithium Ltd | 61 | |
| Andrew Mcknight | MP Materials Corp | 42 | |
Management Performance
| Return On Equity | -3.63 | |||
| Return On Asset | -0.69 |
BioLargo Leadership Team
Elected by the shareholders, the BioLargo's board of directors comprises two types of representatives: BioLargo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLargo. The board's role is to monitor BioLargo's management team and ensure that shareholders' interests are well served. BioLargo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLargo's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dennis Calvert, Chairman, CEO and Pres | ||
| Joseph Provenzano, Executive VP, VP of Operations, Secretary, Director and President of Odor-No-More, Inc | ||
| Richard Smith, Pres Water | ||
| Randall Moore, Science Engineering | ||
| Kenneth Code, Chief Science Officer and Director | ||
| Steven II, Pres Inc | ||
| CFA II, Chief Officer |
BioLargo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is BioLargo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.63 | |||
| Return On Asset | -0.69 | |||
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.16) % | |||
| Current Valuation | 52.87 M | |||
| Shares Outstanding | 275.42 M | |||
| Shares Owned By Insiders | 14.70 % | |||
| Shares Owned By Institutions | 0.04 % | |||
| Price To Earning | (4.54) X | |||
| Price To Book | 10.61 X |
Pair Trading with BioLargo
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLargo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLargo will appreciate offsetting losses from the drop in the long position's value.Moving against BioLargo OTC Stock
| 0.71 | PTAIF | PT Astra International | PairCorr |
| 0.68 | CHKEW | CHKEW Old Symbol Change | PairCorr |
| 0.61 | PCTTW | PureCycle Technologies | PairCorr |
| 0.5 | ADVWW | Advantage Solutions | PairCorr |
| 0.46 | VLY | Valley National Bancorp | PairCorr |
The ability to find closely correlated positions to BioLargo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLargo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLargo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLargo to buy it.
The correlation of BioLargo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLargo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLargo moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLargo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in BioLargo OTC Stock
BioLargo financial ratios help investors to determine whether BioLargo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLargo with respect to the benefits of owning BioLargo security.